USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Cytogen Corpon
Address:
201 College Road East
Princeton Forrestal Center
Princeton, NJ 08540
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $100,000.00 2

Award List:

THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP TECHNIQUES FOR USING MONOCLONAL ANTIBODIES LABELED WITH 212BISMUTH, AN ALPHA PARTICLE-EMITTING RADIONUCLIDE, AS IN VITRO OT IN VIVOCYTOTOXIC AGENTS.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
A dwight lopes , PRINCIPAL INVESTIGATOR
Abstract:
The objective of this project is to develop techniques for using monoclonal antibodies labeled with 212bismuth, an alpha particle-emitting radionuclide, as in vitro ot in vivocytotoxic agents. antibody conjugates will be developed forradioimaging to localize to the tumor site only, with minimal… More

THIS PROJECT WILL DEVELOP A SYSTEM FOR THE REMOVAL OF T LYMPHOCYTES OR TUMOR CELLS FROM BONE MARROW USING IMMOBILIZED MONOCLONAL ANTIBODIES.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Richard c seigel , PRINCIPAL INVESTIGATOR
Abstract:
This project will develop a system for the removal of t lymphocytes or tumor cells from bone marrow using immobilized monoclonal antibodies. the selective removal oft cells from bone marrow using immobilized monoclonal antibodies will provide an effective system for allogenic transplant of bone… More